Reported 40,669,276 shares, up 1,008,177 (2.5%) from the prior quarter.
Reported value -19.9%; share count 2.5% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2021-12-31 | 67870000 |
| 2022-03-31 | 79129000 |
| 2022-06-30 | 79719000 |
| 2022-09-30 | 63851000 |
| 2022-12-31 | 44864888 |
| 2023-03-31 | 0 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q1 2023 | Reduced | 0 | -50,637,571 (-100.0%) | 0 | $0 | 2023-05-15 | |
| Q4 2022 | Added | 50,637,571 | +9,968,295 (24.5%) | < 0.01% | $44,864,888 | 2023-02-14 | |
| Q3 2022 | Added | 40,669,276 | +1,008,177 (2.5%) | < 0.01% | $63,851,000 | 2022-11-15 | |
| Q2 2022 | Added | 39,661,099 | +5,700,215 (16.8%) | < 0.01% | $79,719,000 | 2022-08-15 | |
| Q1 2022 | Added | 33,960,884 | +19,365,130 (132.7%) | < 0.01% | $79,129,000 | 2022-05-16 | |
| Q4 2021 | Added | 14,595,754 | +2,308,379 (18.8%) | < 0.01% | $67,870,000 | 2022-02-14 | |
|
Five years are shown. A free account unlocks the complete reported history.
Unlock full history
|
|||||||
Who else reported the position
244 managers reported SORRENTO THERAPEUTICS INC for Q3 2022.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| STATE STREET CORPORATION This report | Added | 40,669,276 | +1,008,177 | < 0.01% | $63,851,000 | 34 qtrs |
| BlackRock Inc | Added | 34,179,567 | +229,010 | < 0.01% | $53,664,000 | 30 qtrs |
| VANGUARD GROUP INC | Added | 22,516,574 | +1,620,150 | < 0.01% | $35,351,000 | 36 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 7,108,284 | +215,337 | < 0.01% | $11,160,000 | 35 qtrs |
| D E Shaw & Co Inc | Reduced | 5,056,963 | -824,439 | < 0.01% | $7,939,000 | 20 qtrs |
| NORTHERN TRUST CORPORATION | Reduced | 3,437,600 | -12,539 | < 0.01% | $5,398,000 | 35 qtrs |
| JPMorgan Chase & Co | Reduced | 3,027,184 | -241,333 | < 0.01% | $4,753,000 | 22 qtrs |
| The Goldman Sachs Group Inc | Added | 3,010,140 | +1,070,161 | < 0.01% | $4,726,000 | 31 qtrs |
| Rafferty Asset Management LLC | Added | 2,994,674 | +1,243,608 | 0.05% | $4,702,000 | 10 qtrs |
| SUSQUEHANNA INTERNATIONAL GROUP LLP | Added | 2,942,163 | +814,923 | < 0.01% | $4,619,000 | 15 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2022
- Filed
- November 15, 2022
- Filing type
- 13F-HR
- Position type
- COM NEW
Voting authority reported
- Sole
- 39,932,553
- Shared
- 3,500
- None
- 733,223
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.